ERS: Semaglutide May Reduce Risk for Exacerbations of Airway Diseases

THURSDAY, Sept. 10, 2026-- Semaglutide is associated with a significant reduction in airway exacerbations in patients with asthma or chronic obstructive pulmonary disease (COPD), according to a study presented at the annual congress of the...